Litigation Finance in the Transparency Era: Why Capital, Control and Disclosure Now Matter as Much as Merits

For many years, third-party litigation funding operated largely through private contracts.

Funding agreements were negotiated confidentially. Courts often had limited information about the identity of funders. Opposing parties might not know whether outside capital was involved at all.

That model is changing.

In the United States, debate over third-party litigation funding disclosure has intensified at several levels.

The federal Advisory Committee on Civil Rules continues to consider whether the Federal Rules should address litigation-funding disclosure. Its Third-Party Litigation Funding Subcommittee reported in October 2026 that it was continuing work on a possible disclosure rule, including potential approaches under Rule 26, Rule 16 or Rule 7.1-style mechanisms. United States Courts

The volume of submissions itself is significant. During September and October 2026, the federal rules process received multiple suggestions concerning Rule 26 and third-party litigation funding from companies, trade groups, litigation-finance organisations and other stakeholders. United States Courts

At the legislative level, the Litigation Funding Transparency Act of 2026 was introduced in the U.S. Senate with the stated objective of increasing transparency and oversight of third-party litigation funding in certain actions. GovInfo

Individual federal courts are also moving independently. In September 2026, the U.S. District Court for the Western District of Louisiana adopted a rule requiring parties to disclose third-party litigation financing, adding to the uneven but expanding landscape of court-specific disclosure requirements. Reuters

The direction of travel is therefore clear even if the eventual regulatory model remains unsettled:

the existence and identity of third-party capital is becoming more visible.

The word “transparency” can be misleading.

There is a major difference between disclosing that a funder exists and disclosing everything about the funding relationship.

This distinction is already visible in the federal rulemaking discussion.

The Civil Rules Committee’s October 2026 materials suggest that disclosure of the fact of funding may be considerably less controversial than requiring disclosure of the full funding agreement, internal communications, due-diligence material or other commercially sensitive information. United States Courts

That distinction matters.

A requirement to identify the existence of a funding arrangement can serve legitimate purposes:

• identifying judicial conflicts;
• understanding financial interests in litigation;
• addressing questions of control;
• assisting case management;
• and increasing confidence in the integrity of proceedings.

But compulsory disclosure of underwriting analysis, legal assessments, pricing models or communications between counsel and funder raises very different concerns.

Those materials may contain litigation strategy, attorney work product, confidential financial analysis or commercially sensitive information.

The transparency debate is therefore unlikely to resolve into a simple choice between secrecy and disclosure.

The real policy question is more difficult:

What information must be visible to protect the integrity of the legal process without undermining legitimate confidentiality or distorting the economics of litigation finance?

That question will shape the sector for years.

Disclosure is closely connected to another issue: control.

Critics of litigation finance often worry that a party providing substantial capital may acquire influence over strategic decisions, settlement or the conduct of litigation.

The professional rules governing lawyers, however, require counsel to remain independent and to act in the interests of their clients.

That principle is becoming more explicit in regulatory discussion.

In England and Wales, the Solicitors Regulation Authority published guidance in July 2026 on the use and arrangement of third-party litigation funding. It emphasised the need for solicitors to assess funding arrangements in clients’ best interests, maintain independence, manage conflicts and ensure clients receive appropriate information. Solicitors Regulation Authority

The SRA also consulted on further requirements that would specifically address professional conduct in third-party-funded matters. Among the proposed obligations were requirements to maintain independence from the funder, act in the client’s best interests, and disclose confidential information only with informed client consent. Solicitors Regulation Authority

The significance extends beyond consumer claims.

Although much of the SRA’s wider consultation focused on high-volume consumer litigation, its proposed professional-conduct requirements concerning independence and confidentiality were intended to apply more broadly to third-party-funded matters. Solicitors Regulation Authority

This reinforces an important institutional principle:

Capital participation must not become litigation control.

A sophisticated funder may monitor budget, risk, material developments and the economic performance of its investment.

That is fundamentally different from becoming counsel, directing legal strategy or displacing the claimant’s decision-making authority.

The non-interference principle is sometimes treated as a defensive rule—a limitation imposed on funders.

It should increasingly be understood as an institutional strength.

A funder that can demonstrate clear separation between capital provision and legal control is easier for counsel, claimants, courts and regulators to understand.

It also reduces several categories of risk:

• conflicts between claimant and funder;
• interference with counsel’s professional obligations;
• challenges to privilege or confidentiality;
• disputes over settlement authority;
• and reputational concerns around outside influence.

The most credible litigation-finance models therefore do not merely say that counsel remains independent.

They build governance structures that preserve that independence.

That may include:

• written limits on funder authority;
• defined reporting rights;
• clear settlement procedures;
• independent counsel relationships;
• documented conflicts controls;
• and escalation mechanisms where claimant and funder interests diverge.

Transparency and non-interference are therefore connected.

The clearer the governance framework, the easier it becomes to explain the funder’s role without creating the appearance that the funder controls the case.

Not all litigation-funding markets create the same risks.

Commercial litigation funding between sophisticated counterparties presents different concerns from funding arrangements involving large populations of individual consumers.

The SRA’s 2026 work illustrates that distinction.

The regulator said third-party litigation funding can play an important role in access to justice, while also identifying risks to law-firm stability and consumer outcomes in parts of the high-volume claims sector. Solicitors Regulation Authority

Its proposals included requiring law firms using or arranging funding for consumer claims to provide clear funding information to clients, notify the regulator, and maintain funding-risk assessments. Solicitors Regulation Authority

The underlying policy concern is understandable.

Where clients may not be commercially sophisticated, the funding structure must be explained clearly enough for them to understand:

• what the funder is providing;
• what the funder may receive;
• what the law firm’s obligations are;
• what the client remains responsible for;
• and what happens if the claim succeeds or fails.

That is not merely a regulatory burden.

It is a reminder that informed consent is part of institutional legitimacy.

The identity of the funder is only one layer.

The source of the capital may also matter.

Political and legislative debate in the United States has increasingly focused on foreign involvement in litigation funding.

The broader concern is not simply that a non-U.S. investor might finance a lawsuit.

The concern is whether funding could create undisclosed influence, conflicts, national-security exposure or strategic incentives that are not visible to courts or litigants.

That is reflected in current federal legislative proposals and broader debate over foreign funding transparency. GovInfo

The implications for funders are significant.

Institutional capital may increasingly need to be supported by stronger internal systems around:

• source of funds;
• sanctions;
• beneficial ownership;
• investor identity;
• foreign-state exposure;
• AML controls;
• and conflicts screening.

For many professional funders, these controls already exist.

The transparency era may make them more visible.

Litigation finance is often described as transferring financial risk away from the claimant.

But that only works if the funder itself remains financially capable of performing.

This creates another dimension of underwriting:

the claimant may need to underwrite the funder.

A funding agreement can extend for years.

During that time, the claimant and counsel may depend on the funder to pay legal fees, experts, court costs and other expenses.

A failure of funding midway through a case can be extremely disruptive.

The collapse of Fenchurch Legal illustrates why financial resilience deserves attention.

Companies House records show that Fenchurch Legal entered administration on 1 April 2026. Find and Update Company Information The company had operated as a funder in the high-volume claims market, including providing capital for disbursements and working capital. Law Gazette

The lesson should not be overstated: different litigation funders use very different business models, capital structures and risk profiles.

But the institutional principle is important.

A claimant considering third-party funding may reasonably want to understand:

• the funder’s capital base;
• committed versus discretionary capital;
• duration of available capital;
• concentration risks;
• deployment obligations;
• investor redemption exposure;
• and the consequences if the funder itself becomes distressed.

The strongest funders will increasingly regard capital resilience as part of their credibility.

The transparency debate is occurring while substantial capital continues to enter the sector.

In October 2026, Omni Bridgeway announced a US$1 billion fundraising, taking reported assets under management to approximately US$4.2 billion. Reuters

That is an important signal.

Litigation finance is not disappearing under regulatory scrutiny.

It is becoming more institutional.

Larger pools of capital can support:

• larger disputes;
• portfolio transactions;
• longer-duration matters;
• cross-border enforcement;
• law-firm finance;
• and more sophisticated legal-asset strategies.

But institutional capital also brings institutional expectations.

Investors, courts, regulators and counterparties may increasingly expect litigation funders to demonstrate:

• governance;
• financial controls;
• underwriting discipline;
• compliance systems;
• documented decision-making;
• sanctions and AML controls;
• conflicts processes;
• and resilience under stress.

The sector is therefore being pulled in two directions at once:

more capital

and

more scrutiny.

Those forces are not necessarily contradictory.

They may ultimately reinforce one another.

The practical impact of transparency is not limited to compliance.

Disclosure rules can alter litigation strategy.

A defendant that knows a claimant has third-party funding may make assumptions—correctly or incorrectly—about the claimant’s financial position, settlement appetite or ability to continue litigating.

The identity of a funder may also affect:

• conflict checks;
• discovery disputes;
• settlement negotiations;
• security-for-costs applications;
• challenges to standing;
• privilege arguments;
• and case-management decisions.

Funding disclosure can therefore become part of the litigation environment itself.

That means funders should consider disclosure risk before investing.

The relevant questions may include:

• Is funding disclosure mandatory in this forum?
• What must be disclosed?
• When must disclosure occur?
• To whom?
• Does disclosure extend to the agreement?
• Could the agreement become discoverable?
• Could communications with the funder be challenged?
• Does the structure create conflict or control arguments?

Those questions should increasingly form part of underwriting rather than being treated only as post-investment legal issues.

Institutional transparency should not be confused with the elimination of confidentiality.

Litigation finance depends on access to sensitive information.

Funders routinely assess:

• counsel analysis;
• litigation strategy;
• expert reports;
• damages models;
• settlement history;
• enforcement intelligence;
• financial information;
• and internal commercial assessments.

Much of that information cannot responsibly be made public.

The better approach is therefore layered.

Certain information may appropriately be disclosed to courts, regulators or counterparties where required.

Other information should remain confidential because disclosure would undermine the legal process or reveal commercially sensitive analysis.

A mature litigation-finance market needs both:

appropriate transparency

and

appropriate confidentiality.

The challenge is defining the boundary.

A particularly important development is the growing emphasis on what clients understand before they enter a funding arrangement.

The SRA’s 2026 proposals included the use of prominent funding-information documents intended to help consumers understand the arrangement before signing. Solicitors Regulation Authority

This reflects a broader governance principle that is relevant well beyond consumer claims.

Good funding practice should make key commercial terms clear before significant resources are committed.

That may include:

• the nature of the funder’s role;
• whether the funding is non-recourse;
• the basis of the funder’s return;
• the circumstances in which costs may be payable;
• the funder’s information rights;
• who controls litigation;
• termination rights;
• confidentiality;
• and the consequences of settlement or recovery.

In sophisticated commercial transactions, the parties may negotiate those matters extensively.

But the principle remains the same:

Commercial alignment should be established before transaction costs accumulate.

That protects both the claimant and the funder.

One of the most difficult features of the current market is that litigation-funding rules are not developing uniformly.

Different jurisdictions may take different approaches to:

• disclosure;
• licensing;
• champerty and maintenance;
• funder control;
• privilege;
• adverse costs;
• security for costs;
• consumer protection;
• foreign funding;
• and enforceability of funding agreements.

Even within the United States, rules can vary among federal courts, states and individual judges.

The ongoing Rule 26 debate illustrates this fragmentation.

The federal rules process is considering whether a more general disclosure framework is appropriate, while individual courts continue adopting local requirements. United States Courts

For an international funder, regulatory diligence therefore becomes part of deal underwriting.

The legal rules governing the funding agreement may differ from those governing the underlying dispute.

The forum may impose disclosure requirements that affect confidentiality.

A future change in regulation may also alter transaction economics during the life of the investment.

Regulatory risk is no longer peripheral.

It is part of the asset.

The broad direction of travel suggests that informal funding practices will become increasingly difficult to sustain.

Institutional litigation finance is moving toward documented governance.

That includes clearer processes around:

• intake;
• conflicts;
• confidentiality;
• underwriting;
• investment authority;
• funder control;
• client consent;
• disclosure;
• sanctions;
• external diligence;
• capital deployment;
• monitoring;
• and exit.

These controls are not merely administrative.

They create evidence that the funder understood the transaction it was entering and operated within defined limits.

That becomes especially important if the transaction is later examined by:

• a court;
• regulator;
• insolvency officeholder;
• counterparty;
• investor;
• or another funder.

The transparency era therefore rewards institutional discipline.

None of this diminishes the importance of legal merits.

A weak legal case does not become attractive because the funder has excellent compliance systems.

Merits remain foundational.

But a strong case can still become a poor investment if:

• the funding structure cannot withstand regulatory scrutiny;
• control rights create professional problems;
• disclosure destroys key assumptions;
• the funder lacks adequate capital;
• the capital source creates sanctions or political risk;
• or the parties were never commercially aligned.

Modern litigation-finance underwriting must therefore operate across several dimensions simultaneously.

• Legal merits
• Economic recovery
• Capital structure
• Control
• Disclosure
• Regulatory perimeter
• Funder resilience
• Enforcement

That is what institutionalisation looks like.

Litigation finance has reached a stage where greater visibility is unavoidable.

Courts want to understand financial interests in litigation.

Regulators want to protect clients and preserve professional independence.

Legislators are examining foreign capital and disclosure.

Claimants increasingly want to understand whether their funder can perform.

Investors want stronger governance.

And professional funders want rules that preserve legitimate confidentiality while distinguishing institutional finance from opaque or poorly governed arrangements.

The result is not necessarily a smaller litigation-finance market.

It may be a more disciplined one.

The strongest participants will increasingly be those capable of explaining:

who provides the capital;

what rights that capital creates;

where the boundaries of funder influence lie;

what information must be disclosed;

how conflicts are managed;

how long the capital will remain available;

and

how the transaction remains compliant across its entire life.

That is the central lesson of the transparency era:

Merits determine whether a legal claim may succeed. Institutional governance increasingly determines whether litigation capital can support that claim credibly, lawfully and sustainably.